{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:04:02Z","timestamp":1778155442100,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.contraception.2016.02.004","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T02:30:34Z","timestamp":1454985034000},"page":"507-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents"],"prefix":"10.1016","volume":"93","author":[{"given":"Kristina","family":"Gemzell-Danielsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai J.","family":"Buhling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia M.","family":"Dermout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-8699","authenticated-orcid":false,"given":"Eeva","family":"Lukkari-Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Montegriffo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Apter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.02.004_bb0005","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/aogs.12253","article-title":"Teenage pregnancies in the European Union in the context of legislation and youth sexual and reproductive health services","volume":"92","author":"Part","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2016.02.004_bb0010","author":"World Health Organization"},{"key":"10.1016\/j.contraception.2016.02.004_bb0015","author":"National Institute for Health and Clinical Excellence"},{"key":"10.1016\/j.contraception.2016.02.004_bb0020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e3182723b7d","article-title":"Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices","volume":"120","author":"Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.02.004_bb0025","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/AOG.0b013e31827499bd","article-title":"Continuation of reversible contraception in teenagers and young women","volume":"120","author":"Rosenstock","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.02.004_bb0030","author":"Faculty of Sexual and Reproductive Healthcare"},{"key":"10.1016\/j.contraception.2016.02.004_bb0035","doi-asserted-by":"crossref","first-page":"e1244","DOI":"10.1542\/peds.2014-2299","article-title":"Contraception for adolescents","volume":"134","author":"American Academy of Pediatrics","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.contraception.2016.02.004_bb0040","series-title":"Medical eligibility criteria for contraceptive use: fifth edition","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.contraception.2016.02.004_bb0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.02.004_bb0050","author":"Bayer HealthCare Pharmaceuticals Inc"},{"key":"10.1016\/j.contraception.2016.02.004_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.004_bb0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.contraception.2015.01.021","article-title":"Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system","volume":"91","author":"Nahum","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.02.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135309","article-title":"A multicentre, randomized phase III study of two low-dose levonorgestrel intrauterine contraceptive systems: subgroup analyses evaluating efficacy, safety, placement and user satisfaction according to age and parity status","volume":"10","author":"Gemzell-Danielsson","year":"2015","journal-title":"PLoS One"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T11:50:25Z","timestamp":1537012225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0010782416000366"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.02.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}